Christina Schroeder received her MSc in Chemistry from University of Kalmar, Sweden in 1998. She relocated to Australia in 1999 to conduct her PhD at the University of Queensland under supervision of Professor Richard Lewis and Professor David Craik working on the development of an omega-conotoxin pharmacophore. After completing her PhD in 2003, she stayed on at UQ until 2006, when she joined Professor Philip Dawson’s laboratory at The Scripps Research Institute, La Jolla, USA to work on developing palmitoylated peptides as chaperones for infantile Batten disease. In 2007, she joined Professor Philip Hogg’s laboratory at the University of New South Wales in Sydney where she worked on the multimerisation of large proteins via disulfide bonds. In 2011 she was recruited back to UQ to join Professor David Craik’s group working on the structural biology and synthesis of disulfide-rich plant- and venom-derived peptides. Dr Schroeder was awarded an Australian Research Council Future Fellowship in 2016 focussed on using bioactive peptides in drug design and to understand the mode of action of toxins binding to sodium channels and their surrounding membranes with the ultimate goal to develop novel non-addictive pain therapeutics.